Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Coronavirus channel feed
US spends $275M more on Eli Lilly's Covid mAb as about half of supplies have been administered so far
3 years ago
European Commission says it doesn't have texts between president Ursula von der Leyen and Pfizer CEO Albert Bourla
3 years ago
Pharma
FDA's VRBPAC votes in favor of adapting the Covid-19 vaccine to the latest Omicron variant
3 years ago
FDA+
Updating the Covid-19 vaccine: FDA offers a qualified thumbs-up ahead of adcomm
3 years ago
FDA+
Sanofi, GSK tout 72% Omicron efficacy in PhIII trial of next-gen, bivalent shot — with an eye to year-end rollout
3 years ago
R&D
BioNTech breaks ground on first mRNA vaccine manufacturing facility in Africa
3 years ago
Manufacturing
Moderna to secure a UK presence with $1B+ in new manufacturing and R&D facilities
3 years ago
Pharma
Manufacturing
WTO's IP waiver for vaccines is out and the response is generally negative — from all sides
3 years ago
Pharma
FDA authorizes Pfizer, Moderna Covid-19 vaccines for children as young as 6 months
3 years ago
Pharma
FDA+
Bavarian Nordic to test its Covid-19 booster against Pfizer/BioNTech shot in pivotal study
3 years ago
FDA's adcomm votes unanimously in favor of Moderna and Pfizer's Covid-19 vaccines for the youngest children
3 years ago
FDA+
Pfizer's Paxlovid doesn't stack up as well for those who are vaccinated, new data show
3 years ago
Covid-19 roundup: European governments push to renegotiate vaccine contracts — report; As PhII data disappoint, PureTech pulls long Covid program
3 years ago
FDA offers support for Pfizer, Moderna Covid-19 vaccines for the youngest children ahead of adcomm
3 years ago
FDA+
Once promising an alternative shot, Valneva's Covid-19 supply deal with Europe on verge of collapse
3 years ago
Pharma
Sanofi, GSK keep the ball rolling with data on second-gen Covid vaccine candidate
3 years ago
R&D
Pharma groups decry Covid-19 vaccine IP waiver ahead of Geneva conference
3 years ago
Pharma
Unlike 1-day VRBPAC-to-EUA timeline of peers, Novavax’s Covid-19 jab awaits FDA review of recent manufacturing data
3 years ago
WTO approaches a deal early next week for a Covid-19 vaccine IP waiver
3 years ago
Pharma
Moderna says Omicron-specific booster better than current shot, aims for late summer approval
3 years ago
FDA advisors vote 21-0, with one abstention, to authorize Novavax’s Covid-19 vaccine to be the fourth US option
3 years ago
FDA+
Covid-19 roundup: Merck, Ridgeback drop new analyses for molnupiravir; Veru submits EUA for antiviral treatment
3 years ago
R&D
Pascal Soriot wouldn't 'do anything differently' in Covid-19 vaccine development — report
3 years ago
People
Updated: Troubled Emergent claims J&J will owe up to $420M if it pulls the plug on its Covid-19 vaccine
3 years ago
Manufacturing
First page
Previous page
7
8
9
10
11
12
13
Next page
Last page